Keyphrases
Matrix metalloproteinase-9 (MMP-9)
100%
Non-Hodgkin Lymphoma
100%
Core Needle Biopsy
75%
B Cells
73%
Large Cell
73%
Epigallocatechin Gallate
66%
Clear Cell Renal Cell Carcinoma (ccRCC)
66%
Pseudomonas Aeruginosa Keratitis
66%
COVID-19
66%
Interleukin-6 Expression
66%
Melanoma Antigens
66%
High-risk Human Papillomavirus (HR-HPV)
66%
Surabaya
61%
Moxifloxacin
58%
Interleukin-6
55%
T Stage
53%
P16INK4a
53%
Indonesia
45%
P16INK4a Expression
44%
Immunohistochemistry
42%
Rattus Norvegicus
41%
General Hospital
40%
Pathological Findings
38%
Universal Primers
35%
Lung Tumor
35%
Mediastinal Tumor
35%
Interleukin-1β
33%
Myoma Infertility
33%
Fibroepithelial Polyp
33%
Tumor Core
33%
Uterine Myoma
33%
Primary Infertility
33%
In Vitro Approach
33%
Non-malignant Cells
33%
Lymphoid Lesions
33%
FOXP1
33%
Carcinoma in Situ
33%
E6 HPV
33%
High-risk Human Papillomavirus Infection
33%
Cryotherapy
33%
LR-HPV
33%
Eye Drops
33%
Fungal Corneal Ulcer
33%
Interleukin-17 (IL-17)
33%
EMMPRIN
33%
Thymoma
33%
Capsular Invasion
33%
Cervical Precancerous Lesions
33%
P21 Expression
33%
Perirenal Fat Invasion
33%
Medicine and Dentistry
Gelatinase B
100%
Non-Hodgkin Lymphoma
100%
Biopsy Technique
80%
B Cell
75%
Large Cell
73%
COVID-19
66%
Clear Cell Renal Cell Carcinoma
66%
Interleukin 6
66%
Lung Tumor
66%
Protein P53
66%
Histopathology
40%
Infection
39%
Lung
37%
Immunohistochemistry
36%
Mediastinal Tumor
35%
Infertility
33%
Liver Injury
33%
High Calorie Diet
33%
Adenocarcinoma
33%
Cryotherapy
33%
CD147 Antigen
33%
Perirenal Fat
33%
Cytomegalovirus
33%
Melanoma Antigen
33%
Immunoglobulin M
33%
Interleukin 17
33%
Transitional Cell Carcinoma
33%
Liver Biopsy
33%
Vasculotropin
33%
Epigallocatechin Gallate
33%
Interleukin 1
33%
Fibrinogen
33%
Human Papillomavirus Type 16
33%
Squamous Cell Carcinoma
33%
Corneal Ulcer
33%
Uterine Fibroid
33%
Polyp
33%
Pseudomonas aeruginosa
33%
Caloric Restriction
33%
Keratitis
33%
Vulva
33%
In Vitro
33%
Precancerous Condition
33%
Enteritis
33%
Polymerase Chain Reaction
33%
Cancer Growth Factor
33%
Thymus Cancer
33%
Wart Virus
27%
Malignant Neoplasm
25%
Moxifloxacin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 6
100%
Keratitis
66%
Epigallocatechin Gallate
66%
Pseudomonas aeruginosa
66%
Gelatinase B
66%
Moxifloxacin
58%
Disease
45%
Rattus norvegicus
41%
Interleukin 1
33%
Coronavirinae
33%
Liver Injury
33%
Melanoma Antigen
33%
Interleukin 17
33%
Nonhodgkin Lymphoma
33%
Renal Cell Carcinoma
33%
Cornea Ulcer
33%
Precancer
33%
Squamous Cell Carcinoma
33%
Fibrinogen
33%
Lung Cancer
33%
Human Papillomavirus Type 16
33%
Cancer Growth Factor
33%
Neoplasm
30%
Human Papillomavirus
27%
Malignant Neoplasm
22%
Human Papillomavirus Type 18
16%
Cross-Sectional Study
15%
Cornea Perforation
15%
Human Papillomavirus Type 45
11%
Infection
11%
Endophthalmitis
9%
Fibrosis
9%
Cornea Injury
9%
Natamycin
9%
Messenger RNA
7%
Kidney Cancer
6%
Observational Study
6%
Human Papillomavirus Type 52
5%
Wart Virus Vaccine
5%
Uterine Cervix Carcinoma
5%
Inflammation
5%
Human Papillomavirus Type 6
5%
Uterine Cervix Cancer
5%
Antibiotics
5%
